4.5 (66) In stock
Uric acid‐induced pancreatic β-cell dysfunction, BMC Endocrine Disorders
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice
Sensing soluble uric acid by Naip1-Nlrp3 platform
AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model, European Journal of Medical Research
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
Life, Free Full-Text
Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial, Diabetology & Metabolic Syndrome
Recent advances in fructose intake and risk of hyperuricemia - ScienceDirect
JCM, Free Full-Text
Nutrients, Free Full-Text
Frontiers Untargeted metabolomics of saliva in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women
AMPK alleviates high uric acid-induced Na+-K+-ATPase signaling impairment and cell injury in renal tubules
